Cargando…

Lessons from TP53 mutations in breast cancers: from carcinogen fingerprints to clinical correlates

Detalles Bibliográficos
Autores principales:	Hainaut, P, Olivier, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2000
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300839/ http://dx.doi.org/10.1186/bcr140

Ejemplares similares

TP53 and additional pathways in therapy resistance
por: Lønning, PE
Publicado: (2005)

Independent prognostic value of somatic TP53 gene mutations in 1794 breast cancer patients
por: Olivier, M, et al.
Publicado: (2005)

Prognostic value genotypes and LOH at TP53 codon 72 and TP53 mutations in primary breast cancer
por: Kyndi, M, et al.
Publicado: (2005)

Expression of wild-type and mutated TP53 in breast carcinomas
por: Baumbusch, LO, et al.
Publicado: (2005)

TP53 Mutations and HBX Status Analysis in Hepatocellular Carcinomas from Iran: Evidence for Lack of Association between HBV Genotype D and TP53 R249S Mutations
por: Abedi-Ardekani, Behnoush, et al.
Publicado: (2011)

Low Prevalence of TP53 Mutations and MDM2 Amplifications in Pediatric Rhabdomyosarcoma
por: Ognjanovic, Simona, et al.
Publicado: (2012)

HIFU immunotherapy: lessons from animal to clinical studies
por: Wu, Feng
Publicado: (2015)

Characterising Mutational Spectra of Carcinogens in the Tumour Suppressor Gene TP53 Using Human TP53 Knock-in (Hupki) Mouse Embryo Fibroblasts
por: Hölzl-Armstrong, Lisa, et al.
Publicado: (2019)

P257 Amplified fragment length polymorphism fingerprinting supports the absence of correlation of genotype with clinical phenotype or source of the isolate in Aspergillus flavus infections
por: Paul, Raees, et al.
Publicado: (2022)

Gene expression profiles and the TP53 mutation status are powerful prognostic markers of breast cancer
por: Langerød, A, et al.
Publicado: (2005)

The TP53 fertility network
por: Paskulin, Diego d’Avila, et al.
Publicado: (2012)

Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA
por: Li, Xuerui, et al.
Publicado: (2020)

Clinical implications of germline mutations in breast cancer: TP53
por: Schon, Katherine, et al.
Publicado: (2017)

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
por: Langerød, A, et al.
Publicado: (2000)

Osteoporosis in children with chronic illness: lessons from natural history studies that guide clinical practice
por: Ward, Leanne M
Publicado: (2015)

S127: DELTATP73 IMPOSES TP53 MUTANT-LIKE PHENOTYPES INCLUDING DRUG RESISTANCE AND POOR PROGNOSIS ON TP53-WILD TYPE ACUTE MYELOID LEUKEMIA.
por: Pereira-Martins, Diego A, et al.
Publicado: (2023)

Impact of RSBY on enrolled households: lessons from Gujarat
por: Seshadri, Tanya, et al.
Publicado: (2012)

The mouse in preclinical trials: transgenic, carcinogen-induced, or xenograph models – which to use?
por: Brown, P
Publicado: (2003)

Immunohistochemical correlates of TP53 somatic mutations in cancer
por: Murnyák, Balázs, et al.
Publicado: (2016)

From Noordwijkerhout to Bendigo: lessons learnt in developing a high risk foot clinic in regional Australia
por: Perrin, Byron, et al.
Publicado: (2013)

Lessons from tissue-specific KO of CNP/GC-B system - everlasting challenge to clinical application
por: Nakao, Kazuwa, et al.
Publicado: (2013)

Therapeutic targets for rheumatoid arthritis: lessons from animal models
por: Iwakura, Yoichiro, et al.
Publicado: (2012)

Lessons to be learned: best and worst results from a 7 years old clinical database of scoliosis patients
por: Negrini, S, et al.
Publicado: (2012)

TP53 mutations among molecular subtypes of HER2-positive tumors
por: Helland, Å, et al.
Publicado: (2005)

Evaluation of the arrayed primer extension resequencing assay for TP53 mutation detection
por: Due, EU, et al.
Publicado: (2005)

Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients
por: Alsner, J, et al.
Publicado: (2000)

Proof-of-concept in vivo evaluation of targeted therapeutics: lessons from immunoliposomes
por: Benz, CC
Publicado: (2003)

74 Lessons from the COVID-19 Pandemic for Food Supply Chains
por: Anderson, John D, et al.
Publicado: (2021)

The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
por: Leroy, Bernard, et al.
Publicado: (2013)

Recruitment and retention of health professionals in the European Union: lessons from country experiences
por: Dussault, Gilles
Publicado: (2014)

10 The Impact of Global Disasters on Our Pets: Lessons from COVID-19
por: Protopopova, Alexandra
Publicado: (2021)

Mutations in TP53 and CTNNB1 in Relation to Hepatitis B and C Infections in Hepatocellular Carcinomas from Thailand
por: Galy, Olivier, et al.
Publicado: (2011)

ATM mutations associated with breast cancer
por: Gatti, RA, et al.
Publicado: (2005)

TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes
por: Yabe, Mariko, et al.
Publicado: (2021)

TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma
por: Wang, Haiwei, et al.
Publicado: (2022)

The emerging role of HHV-6 in neurologic disease: lesson from multiple sclerosis and epilepsy
por: Jacobson, Steven
Publicado: (2006)

Child growth trajectories to adult disease: lessons from UK birth cohort studies
por: Ong, Ken K
Publicado: (2015)

Estrogen receptor alpha-positive and negative mouse mammary tumors through somatic mutations of p53 in mammary carcinogenesis
por: Lin, S-CJ, et al.
Publicado: (2003)

Prevalence of the TP53 p.R337H Mutation in Breast Cancer Patients in Brazil
por: Giacomazzi, Juliana, et al.
Publicado: (2014)

Correlation of ethnicity with breast density as assessed by Quantra™
por: Tzias, D, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_066550n3j9e8d1tprefukdelce